Fluocinolone Acetonide

A potent corticosteroid that reduces inflammation and itching.

Miconazole

An antifungal agent that treats fungal infections like ringworm and athlete's foot.

Neomycin

An antibiotic that combats bacterial infections.

Treatment of inflammatory dermatoses complicated by secondary bacterial and/or fungal infections.

Conditions such as eczema, psoriasis, and seborrheic dermatitis when accompanied by bacterial or fungal infections.

Fluocinolone acetonide suppresses inflammation by binding to intracellular receptors, inhibiting the release of inflammatory mediators. Miconazole disrupts fungal cell membranes, leading to fungal cell death. Neomycin inhibits bacterial protein synthesis, resulting in bacterial cell death. The combination provides broad-spectrum antimicrobial and anti-inflammatory action.

Store at room temperature, away from direct sunlight and moisture. Keep out of reach of children. Discard any unused portion after the expiry date.

Apply a thin layer to the affected area twice daily.

Dosage and duration of treatment should be determined by a healthcare professional based on the severity of the condition and patient response.

Do not exceed the recommended dosage without consulting a doctor.

Burning, stinging, or itching at the application site.

Skin thinning (atrophy).

Striae (stretch marks).

Increased skin sensitivity to sunlight.

Allergic contact dermatitis.

Secondary infection.

Alcohol Consumption

No specific interactions reported, but excessive alcohol use can negatively impact skin health.



While Driving or operating Machinery

Generally safe, unless side effects like dizziness or visual disturbances occur.



Pregnant & Breastfeeding Women

Consult a doctor before use. Use only if the benefits outweigh potential risks to the fetus or infant.



Children

Use with caution, under a doctor's supervision, due to increased risk of systemic absorption.



Kidney

No specific concerns, but patients with severe renal impairment should be monitored.



Liver

No specific concerns, but patients with severe hepatic impairment should be monitored.

Consult your doctor or pharmacist for specific references to package inserts and medical journals.